These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
576 related articles for article (PubMed ID: 15123230)
21. Bronchodilator effect of an inhaled combination therapy with salmeterol + fluticasone and formoterol + budesonide in patients with COPD. Cazzola M; Santus P; Di Marco F; Boveri B; Castagna F; Carlucci P; Matera MG; Centanni S Respir Med; 2003 May; 97(5):453-7. PubMed ID: 12735659 [TBL] [Abstract][Full Text] [Related]
22. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma. Dahl R; Chuchalin A; Gor D; Yoxall S; Sharma R Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212 [TBL] [Abstract][Full Text] [Related]
23. Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids. Kaiser H; Parasuraman B; Boggs R; Miller CJ; Leidy NK; O'Dowd L Ann Allergy Asthma Immunol; 2008 Sep; 101(3):295-303. PubMed ID: 18814453 [TBL] [Abstract][Full Text] [Related]
24. Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study. Kuna P Clin Drug Investig; 2010; 30(9):565-79. PubMed ID: 20593912 [TBL] [Abstract][Full Text] [Related]
25. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol. Frois C; Wu EQ; Ray S; Colice GL Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019 [TBL] [Abstract][Full Text] [Related]
26. Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study. Aalbers R Clin Drug Investig; 2010; 30(7):439-51. PubMed ID: 20528000 [TBL] [Abstract][Full Text] [Related]
27. Onset of bronchodilation with fluticasone/formoterol combination versus fluticasone/salmeterol in an open-label, randomized study. Aalbers R; Brusselle G; McIver T; Grothe B; Bodzenta-Lukaszyk A Adv Ther; 2012 Nov; 29(11):958-69. PubMed ID: 23081745 [TBL] [Abstract][Full Text] [Related]
28. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma. Akamatsu T; Shirai T; Kato M; Yasui H; Hashimoto D; Fujisawa T; Tsuchiya T; Inui N; Suda T; Chida K Pulm Pharmacol Ther; 2014 Feb; 27(1):52-6. PubMed ID: 23583566 [TBL] [Abstract][Full Text] [Related]
29. Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction. Politiek MJ; Boorsma M; Aalbers R Eur Respir J; 1999 May; 13(5):988-92. PubMed ID: 10414394 [TBL] [Abstract][Full Text] [Related]
30. Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety. Bodzenta-Lukaszyk A; Buhl R; Balint B; Lomax M; Spooner K; Dissanayake S J Asthma; 2012 Dec; 49(10):1060-70. PubMed ID: 23102189 [TBL] [Abstract][Full Text] [Related]
31. Acute care among asthma patients using budesonide/formoterol or fluticasone propionate/salmeterol. Blais L; Beauchesne MF; Forget A Respir Med; 2009 Feb; 103(2):237-43. PubMed ID: 18930647 [TBL] [Abstract][Full Text] [Related]
32. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler. Berger WE; Noonan MJ J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601 [TBL] [Abstract][Full Text] [Related]
33. Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? Vogelmeier C; D'Urzo A; Pauwels R; Merino JM; Jaspal M; Boutet S; Naya I; Price D Eur Respir J; 2005 Nov; 26(5):819-28. PubMed ID: 16264042 [TBL] [Abstract][Full Text] [Related]
34. Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Kuna P; Peters MJ; Manjra AI; Jorup C; Naya IP; Martínez-Jimenez NE; Buhl R Int J Clin Pract; 2007 May; 61(5):725-36. PubMed ID: 17362472 [TBL] [Abstract][Full Text] [Related]
35. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma]. Korn S; Vogelmeier C; Buhl R Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216 [TBL] [Abstract][Full Text] [Related]
36. Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma. Johansson G; Andreasson EB; Larsson PE; Vogelmeier CF Pharmacoeconomics; 2006; 24(7):695-708. PubMed ID: 16802845 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma. Balanag VM; Yunus F; Yang PC; Jorup C Pulm Pharmacol Ther; 2006; 19(2):139-47. PubMed ID: 16009588 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of Seretide (50/250 microg bd Diskus vs. formoterol (12 microg bd) and budesonide (800 microg bd) given concurrently (both via Turbuhaler) in patients with moderate-to-severe asthma. Ringdal N; Chuchalin A; Chovan L; Tudoric N; Maggi E; Whitehead PJ; Respir Med; 2002 Nov; 96(11):851-61. PubMed ID: 12418582 [TBL] [Abstract][Full Text] [Related]
40. Combination therapy in asthma--fixed or variable dosing in different patients? Lötvall J Curr Med Res Opin; 2004 Nov; 20(11):1711-27. PubMed ID: 15537472 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]